XellSmart’s off-the-shelf XS411 lifted motor scores in nine patients, and its 30-person Phase II trial has finished enrolling ...
Rapalogix reports firmer, more elastic skin in a double-blind study of its longevity serum, and the details are worth a close ...
Sironax is about halfway to its enrollment target in a Phase 2 trial of an oral NAMPT activator for adults with obesity.
Cognito Therapeutics and the state’s Life Science Hub are building a statewide platform around its Alzheimer’s therapy, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results